John P. Schmid

Companies

• BlossomHill Therapeutics, Inc.Board member Aug 6, 2026 to now¹
• First Tracks Biotherapeutics, Inc.Board member Apr 1, 2026 to now²
• Helix Acquisition Corp. IIIBoard member Jan 22, 2026 to now³
• Design Therapeutics, Inc.Board member Mar 25, 2021 to now⁴
• ANAPTYSBIO, INCBoard member Jan 25, 2017 to now⁵
• Poseida Therapeutics, Inc.Board member Jul 9, 2020 to Jan 8, 2025⁶
• Xeris Biopharma Holdings, Inc.Board member Oct 5, 2021 to Aug 13, 2024⁷
• BridgeBio Oncology Therapeutics, Inc.Board member Feb 9, 2024 to Feb 9, 2024⁸
• MoonLake ImmunotherapeuticsBoard member Oct 19, 2020 to Oct 19, 2020⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AANAPTYSBIO, INC ANAB37,652 shares¹⁰$1.8M at $47.42Jun 15, 2026
• XBXeris Biopharma Holdings, Inc. XERS138,359 shares¹¹$1.4M at $10.09Aug 13, 2024
• FTFirst Tracks Biotherapeutics, Inc. TRAX37,652 shares¹²$1.3M at $35.31Jun 15, 2026
• DTDesign Therapeutics, Inc. DSGN57,639 shares¹³$594.3K at $10.31Mar 25, 2024
• BOBridgeBio Oncology Therapeutics, Inc. BBOT30,000 shares¹⁴$84.6K at $2.82Aug 11, 2025
• BTBlossomHill Therapeutics, Inc. BLSM6,000 shares¹⁵$83.6K at $13.94Aug 10, 2026
• PTPoseida Therapeutics, Inc.0 shares¹⁶Jan 8, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 10, 2026Bought 6,000 shares at $16.00 of BlossomHill Therapeutics, Inc.¹⁵
• Jun 15, 2026Exercised options 6,030 shares of ANAPTYSBIO, INC¹⁰
• Jun 15, 2026Exercised options 6,030 shares of First Tracks Biotherapeutics, Inc.¹²
• Mar 30, 2026Sold 522 shares at $57.40 of ANAPTYSBIO, INC¹⁷
• Mar 30, 2026Sold 7,527 shares at $56.70 of ANAPTYSBIO, INC¹⁷
• Mar 30, 2026Sold 12,596 shares at $55.71 of ANAPTYSBIO, INC¹⁷
• Dec 23, 2025Other 11,068 shares at $51.00 of ANAPTYSBIO, INC¹⁸
• Aug 11, 2025Exercised options 30,000 shares of BridgeBio Oncology Therapeutics, Inc.¹⁴
• Jun 15, 2025Exercised options 6,030 shares of ANAPTYSBIO, INC¹⁹
• Mar 25, 2025Other 11,068 shares at $18.18 of ANAPTYSBIO, INC²⁰
• Jan 13, 2025Exercised options 20,645 shares at $8.54 of ANAPTYSBIO, INC²¹
• Jan 13, 2025Exercised options 21,692 shares at $4.55 of ANAPTYSBIO, INC²¹
• Jan 8, 2025U 58,950 shares of Poseida Therapeutics, Inc.¹⁶
• Aug 12, 2024Bought 4,515 shares at $2.25 of Xeris Biopharma Holdings, Inc.¹¹
• Aug 9, 2024Bought 4,285 shares at $2.37 of Xeris Biopharma Holdings, Inc.²²
• Jun 17, 2024Granted 19,650 shares of Poseida Therapeutics, Inc.²³
• Jun 15, 2024Exercised options 3,900 shares of ANAPTYSBIO, INC²⁴
• Jun 5, 2024Granted 50,000 shares of Xeris Biopharma Holdings, Inc.²⁵
• May 10, 2024Bought 5,400 shares at $1.91 of Xeris Biopharma Holdings, Inc.²⁶
• Mar 25, 2024Bought 17,809 shares at $3.74 of Design Therapeutics, Inc.¹³
• Mar 22, 2024Bought 9,156 shares at $3.62 of Design Therapeutics, Inc.¹³
• Mar 14, 2024Bought 4,500 shares at $2.16 of Xeris Biopharma Holdings, Inc.²⁷
• Nov 16, 2023Bought 6,500 shares at $1.51 of Xeris Biopharma Holdings, Inc.²⁸
• Jun 15, 2023Granted 19,650 shares of Poseida Therapeutics, Inc.²⁹
• Jun 7, 2023Granted 42,500 shares of Xeris Biopharma Holdings, Inc.³⁰